Related references
Note: Only part of the references are listed.Global incidence of serogroup B invasive meningococcal disease: a systematic review
Shruti Sridhar et al.
LANCET INFECTIOUS DISEASES (2015)
Cost-utility analysis of treating out of hospital cardiac arrests in Jerusalem
Gary M. Ginsberg et al.
RESUSCITATION (2015)
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
Giannina Izquierdo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
Marcello Tirani et al.
PLOS ONE (2015)
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C. Read et al.
LANCET (2014)
THE CLINICAL FEATURES AND LONG-TERM SEQUELAE OF INVASIVE MENINGOCOCCAL DISEASE IN CHILDREN
Chen Stein-Zamir et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
Hong Anh T. Tu et al.
VACCINE (2014)
Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2014)
Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
Hannah Christensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010)
S. Ben-Shimol et al.
INFECTION (2013)
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
Timo Vesikari et al.
LANCET (2013)
Novel assessment of a novel meningitis B vaccine
Christopher J. Gill
LANCET INFECTIOUS DISEASES (2013)
The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada
Julie A. Bettinger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
Hannah Christensen et al.
VACCINE (2013)
Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage
Valerie Delbos et al.
VACCINE (2013)
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage (Publication with Expression of Concern. See vol. 38, pg. 5577, 2020)
Giacomo Frosi et al.
VACCINE (2013)
Counting the Cost of Meningococcal Disease Scenarios of Severe Meningitis and Septicemia
Claire Wright et al.
PEDIATRIC DRUGS (2013)
Cost-effectiveness of vaccination against meningococcal B among Dutch infants Crucial impact of changes in incidence
Koen B. Pouwels et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Corticosteroids for acute bacterial meningitis
Matthijs C. Brouwer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial
Nicoletta Gossger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study
Russell M. Viner et al.
LANCET NEUROLOGY (2012)
Bexsero A multicomponent vaccine for prevention of meningococcal disease
Andrew R. Gorringe et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Effectiveness of Serogroup C Meningococcal Conjugate Vaccine A 7-Year Follow-up in Quebec, Canada
Philippe De Wals et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Long-term Sequelae of Childhood Bacterial Meningitis An Underappreciated Problem
Aruna Chandran et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
Richard Arnold et al.
VACCINE (2011)
Meningococcal carriage by age: a systematic review and meta-analysis
Hannah Christensen et al.
LANCET INFECTIOUS DISEASES (2010)
Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis
Karen Edmond et al.
LANCET INFECTIOUS DISEASES (2010)
Surviving meningococcal septic shock in childhood: long-term overall outcome and the effect on health-related quality of life
Corinne M. P. Buysse et al.
CRITICAL CARE (2010)
Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock
C. M. P. Buysse et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2009)
Long-term Health Status in Childhood Survivors of Meningococcal Septic Shock
Corinne M. P. Buysse et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2008)
Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci
Stephanie Dellicour et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006
Anne McNicholas et al.
HUMAN VACCINES (2007)
Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model
CL Trotter et al.
MEDICAL DECISION MAKING (2006)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease
J Holst et al.
VACCINE (2003)
Vaccinating first-year college students living in dormitories for meningococcal disease - An economic analysis
RD Scott et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2002)
Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000
CM Healy et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
